*The author thanks Professor Marc Perlman (Brown University) for his comprehensive notes on the IGC deliberations of 3 June 2016.
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) On May 19th, 2016 the NIH posted a notice on the Federal Register stating it is contemplating the grant of an exclusive license to Etubics… Continue Reading
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) On May 19th, 2016 the NIH posted a notice on the Federal Register stating it is contemplating the grant of an exclusive license to IntelliPanel… Continue Reading
By Sophia Simon
This week, the World Intellectual Property Organization (WIPO) is convening the 30th session of the Intergovernmental Committee (IGC) on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (GRTKF) from 30 May 2016 to 3 June 2016. The goal of this week’s session is to “[u]ndertake negotiations on [genetic resources] GRs with a focus on addressing unresolved issues” and to consider “options for a draft legal instrument.” The Committee is chaired by Ian Goss (Australia).
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) On May 18th, 2016 the NIH posted a notice on the Federal Register stating it is contemplating the grant of an exclusive license to Dimension… Continue Reading
In October 2015 the General Assembly of the World Intellectual Property Organization (WIPO) renewed the mandate of the the Intergovernmental Committee on Genetic Resources, Traditional Knowledge and Folklore (GRTKF):
The following is the intervention on behalf of Stichting Health Action International (HAI) at 69th World Health Assembly, Agenda Item 11.3 – Framework of engagement with non-State actors.
KEI worked with HAI on the statement, and the statement was delivered by Thiru Balasubramaniam
Saturday, 28 May 2016
WHA69: Resolution WHA69.23 on CEWG follow-up charts course for WHO’s work on R&D
For more information, contact:
(U.S.) Andrew Goldman, KEI: andrew.goldman@keionline.org or +1 (202) 332-2670
(Colombia) Andrea Carolina Reyes Rojas, Misión Salud: subdireccion@mision-salud.org
(Colombia) Dr. Francisco Rossi, IFARMA: francisco_rossi@hotmail.com
(More on Colombia here: /colombia)
Contact:
(U.S.) Andrew Goldman, KEI: andrew.goldman@keionline.org or +1 (202) 332-2670
(Colombia) Andrea Carolina Reyes Rojas, Misión Salud: subdireccion@mision-salud.org
(Colombia) Dr. Francisco Rossi, IFARMA: francisco_rossi@hotmail.com
(More on Colombia here: /colombia)
Washington, DC — Today, 28 organizations that support the advancement of public health, as well as the successful continuation of the peace process in Colombia, urged President Obama to voice U.S. support for Colombia’s right to grant a compulsory license on an expensive leukemia drug. Continue Reading